Product
Membrane Bound Cytokine Modified TIL
1 clinical trial
4 indications
Indication
Advanced Gynecologic TumorsIndication
Side EffectsIndication
ImmunotherapyClinical trial
A Clinical Study on TIL Engineered With Membrane-Binding Cytokine for the Treatment of Advanced Gynecologic TumorsStatus: Recruiting, Estimated PCD: 2024-03-10